“But it’s people who work tirelessly when we need them most, and people who cure the incurable. “Healthcare will forever be a human-and-labor intensive industry,” said Streat. By simplifying large, complex, and legacy datasets, DexCare resolves workforce constraints, and provides the levers to precisely coordinate scheduling, across services and modalities, to optimize capacity and operational costs. The platform enables healthcare systems to forecast and predict demand and manage how and where care is merchandized to consumers – throughout the digital ecosystem. In addition, health systems are confronted with rising costs that outpace growth, and a digital-care experience that falls short of post-pandemic consumer expectations.ĭexCare is a care-access platform to manage the logistics of digital-care delivery. More than 100 million Americans face some kind of care-access barrier, a result of rural hospital closures and physician shortages. On the back-end, it helps health systems optimize and unlock capacity, which is ultimately better for patient care and more sustainable for health systems.” “On the front-end, DexCare’s platform makes finding care as easy as ecommerce.

“Accessing quality care is a two-sided problem, and DexCare has built a solution that addresses both sides of this equation,” said Caroline Xie, general partner at ICONIQ Growth, and newest member of the DexCare board.

The funding round included participation from existing partners Transformation Capital, Kaiser Permanente Ventures, Define Ventures, Frist Cressey Ventures, and SpringRock Ventures. Together, DexCare and its partners have the runway to modernize the legacy data-and-platform infrastructures to realize a healthcare ecosystem that works for everyone. The addition of ICONIQ Growth – who has partnered with companies defining the future of their industries like Adyen, Datadog, GitLab, Miro, and Snowflake – brings a track record of disruption and positive change. With the backing of our investors, partners and customers, we’re overhauling an antiquated industry to ensure patients are matched to the right provider, at the right time, and in the right setting.” “We’re staring at a new era of care delivery,” said Streat, “and this financing validates DexCare’s impact to modernize health commerce, from how care is accessed and orchestrated to delivered. The pandemic taught us that consumers want convenience and choice, and that health systems need controls to manage the supply of care – DexCare delivers both. “The trauma caused on the frontlines, as health systems rushed to care for their communities, stressed an already high level of provider and nurse burnout. healthcare system,” said Derek Streat, CEO of DexCare. “We’re just emerging from an unpredictable moment in history that cast a spotlight on a strained U.S. The new funding brings the total raised to $146 million, including two oversubscribed rounds closed in less than two years. The funding will advance DexCare’s platform, which extends limited health-system capacity to serve patients faster and to precisely manage the supply and demand of digital-care access. SEATTLE-( BUSINESS WIRE)- DexCare, Inc., the leading patient demand and care access platform, today announced the close of its $75 million Series C funding round led by ICONIQ Growth.

Rpabased series iconiq growth